By Nadia Dreid ( May 10, 2021, 8:12 PM EDT) -- GlaxoSmithKline has convinced the United Kingdom's competition appeal body to significantly slash the £37.6 million ($53.1 million) fine it was hit with half a decade ago for paying to keep generic versions of the antidepressant Seroxat off the market, according to new documents....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.